Graymark Healthcare Treats Record Number of Patients in Q4 2010

Q4 2010 Sleep Apnea Re-Supply Orders up 75% Over Q4 2009

Graymark Healthcare Inc, the nation’s second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), serviced a record number of OSA patients in the fourth quarter of 2010, with a 16% increase in set-ups and a 75% increase in re-supply shipments, as compared to fourth quarter of 2009.

Graymark specializes in the diagnosis and treatment of sleep apnea, which is characterized by abnormal pauses in breathing during sleep where each pause or “apnea” can last from a few seconds to minutes, and can occur from five to more than 30 times per hour. OSA is the most common form of sleep apnea, where the soft tissue in the airway obstructs breathing. OSA correlates highly with stroke, cardiac disease, obesity and other conditions that lead to early death and morbidity. However, 80% of patients affected by OSA go completely undiagnosed and patient treatment compliance is often a challenge.

In an effort to improve clinical outcomes, Graymark has been pioneering better techniques to more quickly and effectively diagnosis and treat patients diagnosed with OSA. In the fourth quarter of 2009, Graymark Healthcare launched a new comprehensive care model to improve the conversion rate of OSA patients into successfully using a (Continuous Positive Airway Pressure) device.

Graymark’s effective five-step clinical approach to managing sleep disorders includes a convenient referral process, accurate and timely assessment, diagnosis, treatment and long-term follow-up to maximize patient compliance. All steps are managed by a board certified Sleep Medicine physician. By more completely integrating the diagnostic and treatment processes, Graymark has substantially improved patient compliance with care and overall disease management.

“There are many measures for patient compliance used in our industry, but the fact that our patients continue to buy supplies for their device is the best indicator they are using their device as intended,” said Stanton Nelson, chairman and CEO of Graymark Healthcare. “In 2010, we provided initial set-up for more than 3,000 OSA patients and shipped more than 6,400 re-supply orders.”

The Graymark Healthcare OSA therapy program ensures that patients are effectively supported in their initial use of a device and that challenges are addressed quickly and effectively to reduce rates of therapy abandonment. Similarly, the re-supply program provides regular follow-up care and ensures that disposable elements of the are cleaned and replaced consistent with manufacturer set schedules. Patients who are found not compliant with care are provided additional support to optimize their utilization of the device.

Source: Graymark Medical

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA *